The Data-Driven Diagnostics Company

Our unique approach combines expertise in gastrointestinal oncology, digital pathology and AI-driven biomarker discovery.

A global problem

Every year, over 5 million people are diagnosed with cancer in their
digestive system.

Rising incidence

One of the deadliest cancers occurs in the esophagus, with cases growing at an alarming rate.

Symptoms like heartburn can cause Barrett’s Esophagus, a precursor to cancer.

9 out of every 10 affected patients are undiagnosed.

Symptoms like heartburn can cause Barrett’s Esophagus, a precursor to cancer.

9 out of every 10 affected patients are undiagnosed.

Poor survival

Some patients with Barrett’s will develop advanced esophageal cancer and have a devastating five-year survival rate of less than 15%.

Diagnostics are the bottleneck

It is impossible to perform an invasive endoscopy on every patient at risk of esophageal cancer.

This needs to change

  1. 2022
  2. 2023
  3. 2024
  4. 2025
  5. 2026

Diagnosing cancer
earlier and faster

Our technologies give doctors access to less invasive and better diagnostics for diseases such as Barrett’s esophagus, so we can reduce deaths from late-stage cancer.

Work with the emerging leader in digital diagnostics and transform healthcare

Careers

What we do

Cytosponge™

Detecting Esophageal cancer early

The Cytosponge test is a combination of a swallowable pill on a string for cell collection and a diagnostic test to identify patients at risk of esophageal cancer by detecting its precursor: Barrett’s Esophagus.

Learn more

Cyted Laboratories

Improving patient care

We provide histopathology as a service to public as well as private healthcare providers. Through our unique clinical pathway and data platform, we are positioned to change patient journeys by leveraging pathology data at scale.

Learn more

Find out how we are
leading a revolution in diagnostics

Image pasta couple2